Basic principles of intravenous immunoglobulin (IVIg) treatment.
about
Intravenous immunoglobulins for the treatment of infections in patients with haematological cancersIntravenous immunoglobulins for the treatment of infections in patients with haematological cancersTreatment of spinal cord injury with intravenous immunoglobulin G: preliminary evidence and future perspectivesImpact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms.Use of Fc-Engineered Antibodies as Clearing Agents to Increase Contrast During PET.May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?Optimization of immunoglobulin substitution therapy by a stochastic immune response model.Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model.Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury.Monoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases.Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.Antibody-based therapy in Alzheimer's disease.Management of acute and refractory Kawasaki disease.Atypical guillain-barré in the emergency department.New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins.Antibody therapies for the prevention and treatment of viral infections.Efficiency of long-term treatment with intravenous immunoglobulins correlates with reduced autoreactive T cell responses in chronic inflammatory demyelinating polyneuropathy patients
P2860
Q24186274-387108AB-EC88-4D32-8599-23BB53869EF8Q24236448-950EFA0B-4601-46BE-8232-16BC736F3476Q26822442-FD91E1D9-329D-402A-BC6C-84EAEAC67B02Q30252123-F050C829-195C-4F41-9064-ACA009CDF300Q30659434-B2037FFB-E70A-49BA-B4E3-5CB10BD99B3EQ33408852-9000E52C-1E6E-469F-A312-CD9784160EAFQ33455748-E7F210BF-7543-4717-A237-68ECDA4F56CCQ35170050-D1B65DD5-27BC-432C-A614-861FD2B439EBQ36416677-512E1D0F-96F3-4D32-AE1C-D70B2197C0DBQ36922576-7F82ABED-ACE3-4673-89E3-71E90D476D14Q37091310-5C51429B-0FAD-4B5D-90A8-61617B143968Q37831912-C5890C6A-8C9A-4ABE-A5F8-50E6E5B61633Q38063969-4D158ACE-7D33-434C-B6E0-A2F92132A4F7Q39934602-3456B56B-30A3-4932-8C70-42ED189F0198Q41173378-F9AD764C-7312-451C-9D93-649EE908D6FBQ47143843-EEDAD29E-A230-4A3E-B988-E5BD6356FEF6Q56960415-1CE3A565-50BE-4012-8B37-15508DDD7560
P2860
Basic principles of intravenous immunoglobulin (IVIg) treatment.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Basic principles of intravenous immunoglobulin (IVIg) treatment.
@ast
Basic principles of intravenous immunoglobulin (IVIg) treatment.
@en
type
label
Basic principles of intravenous immunoglobulin (IVIg) treatment.
@ast
Basic principles of intravenous immunoglobulin (IVIg) treatment.
@en
prefLabel
Basic principles of intravenous immunoglobulin (IVIg) treatment.
@ast
Basic principles of intravenous immunoglobulin (IVIg) treatment.
@en
P2860
P1433
P1476
Basic principles of intravenous immunoglobulin (IVIg) treatment.
@en
P2093
Martin Stangel
P2860
P2888
P304
P356
10.1007/S00415-006-5003-1
P478
253 Suppl 5
P577
2006-09-01T00:00:00Z